These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15453324)

  • 1. [Advances in the treatment of acute hepatitis B].
    Mochida S; Fujiwara K
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():248-52. PubMed ID: 15453324
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent advances in the treatment of fulminant hepatitis B].
    Yoshiba M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():280-3. PubMed ID: 15453330
    [No Abstract]   [Full Text] [Related]  

  • 3. Apparent cure of hepatitis C virus carrier state after hepatitis B virus superinfection.
    Yoshinaga S; Fukushima S; Masaki N; Hayashi S
    Jpn J Infect Dis; 1999 Oct; 52(5):220. PubMed ID: 10680091
    [No Abstract]   [Full Text] [Related]  

  • 4. Very few hepatitis trials recruiting.
    AIDS Patient Care STDS; 1998 Apr; 12(4):319-20. PubMed ID: 11361965
    [No Abstract]   [Full Text] [Related]  

  • 5. Simultaneous acute myeloid leukaemia and de novo acute hepatitis B: a novel management strategy.
    Parrish C; Moreton P; Ashcroft J
    Leuk Res; 2011 Jun; 35(6):e67-8. PubMed ID: 21168208
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined interferon plus lamivudine treatment in young patients with dual HBV (HBeAg positive) and HCV chronic infection.
    Marrone A; Zampino R; D'Onofrio M; Ricciotti R; Ruggiero G; Utili R
    J Hepatol; 2004 Dec; 41(6):1064-5. PubMed ID: 15582146
    [No Abstract]   [Full Text] [Related]  

  • 7. Designing clinical development programs for anti-hepatitis B virus drugs.
    Brown NA
    Methods Mol Med; 2004; 96():499-537. PubMed ID: 14762289
    [No Abstract]   [Full Text] [Related]  

  • 8. [New advances in the treatment of chronic hepatitis B: position of entecavir].
    Olaso V
    Rev Esp Quimioter; 2007 Sep; 20(3):259-60. PubMed ID: 18080023
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evolution of hepatitis B virus quasispecies during lamivudine-entecavir sequential therapy].
    Liu L; Tang YZ; Li JG; Zhou JJ; Wang XH; Wang YM
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jun; 18(6):423-7. PubMed ID: 20587311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
    Acar A; Görenek L; Aydin A; Eyigün CP; Eken A; Sayal A; Pahsa A
    Mikrobiyol Bul; 2009 Jul; 43(3):411-23. PubMed ID: 19795616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Consensus document of the Spanish Association for the Study of the Liver on the treatment of hepatitis B infection (2012)].
    Buti M; García-Samaniego J; Prieto M; Rodríguez M; Sánchez-Tapias JM; Suárez E; Esteban R
    Gastroenterol Hepatol; 2012; 35(7):512-28. PubMed ID: 22749508
    [No Abstract]   [Full Text] [Related]  

  • 12. The controversial role of lamivudine prophylaxis in occult HBV carriers treated with chemo-immune therapy.
    D'Andrea M; Nosotti L; Pimpinelli F; Dessanti ML; Paviglianiti A; Miglioresi L; Morrone A; Petti MC
    Dig Liver Dis; 2009 Nov; 41(11):839-40. PubMed ID: 19464241
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiviral agents: the road from scepticism to efficacy.
    Galasso GJ
    Acta Microbiol Acad Sci Hung; 1981; 28(3):313-24. PubMed ID: 6171143
    [No Abstract]   [Full Text] [Related]  

  • 14. Regression of indolent B-cell lymphoma after Lamivudine prophylaxis of hepatitis B virus infection.
    Arcaini L; Merli M; Rattotti S; Bruno R; Vercelli A; Lucioni M; Riboni R; Paulli M
    J Clin Oncol; 2011 Jun; 29(18):e543-5. PubMed ID: 21482990
    [No Abstract]   [Full Text] [Related]  

  • 15. The hepatitis B carrier state.
    Murray BJ
    Am Fam Physician; 1986 Apr; 33(4):127-33. PubMed ID: 2938461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamivudine in the treatment of polyarteritis nodosa associated with acute hepatitis B.
    Gupta S; Piraka C; Jaffe M
    N Engl J Med; 2001 May; 344(21):1645-6. PubMed ID: 11374371
    [No Abstract]   [Full Text] [Related]  

  • 17. Entecavir is a potent anti-HBV drug superior to lamivudine: experience from clinical trials in China.
    Yao G
    J Antimicrob Chemother; 2007 Aug; 60(2):201-5. PubMed ID: 17556353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Entecavir to treat severe acute hepatitis B.
    De Socio GV; Mercuri A; Di Candilo F; Baldelli F
    Scand J Infect Dis; 2009; 41(9):703-4. PubMed ID: 19544224
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful Treatment of Hepatitis B Virus-associated Membranous Nephropathy with Entecavir and Immunosuppressive Agents.
    Ochi A; Ishimura E; Ichii M; Ohno Y; Nakatani S; Kobayashi I; Shima H; Tsuda A; Shidara K; Mori K; Tamori A; Inaba M
    Nephrology (Carlton); 2014 Sep; 19(9):595-6. PubMed ID: 25156438
    [No Abstract]   [Full Text] [Related]  

  • 20. Entecavir.
    Opio CK; Lee WM; Kirkpatrick P
    Nat Rev Drug Discov; 2005 Jul; 4(7):535-6. PubMed ID: 16075486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.